Topix is the independent leader in professional & natural consumer skincare with a differentiated portfolio of clinically-proven products and brands sold across high-growth channels. Through its professional skincare segment, Topix develops custom brands created in partnership with leading dermatologists and sells to professional spas though the ClarityRx brand. Topix’s family of consumer brands include DermaE, the fastest growing skincare brand in the natural channel and Think, the leader in safe and clean sun care. Topix has a fully integrated platform with capabilities leveraged across all segments, including a robust library of proprietary and efficacious formulas and digital and omnichannel distribution across business lines. Topix is headquartered in New York where it maintains FDA-certified R&D and manufacturing capabilities and employs approximately 550 people.
New Mountain’s investment in Topix was driven by our firm’s multi-year and proactive “deep-dive” efforts in the life sciences, health & wellness, aesthetics, and niche consumer products sectors. New Mountain first began a dialogue with Topix’s founder and CEO in March 2015. Topix decided that New Mountain’s deep expertise in healthcare products as well as its focus on growth and business-building made it the ideal partner to help Topix continue its growth and achieve the next level of success. Throughout diligence, New Mountain was able to leverage its broad network of relationships with industry executives and physicians, developed through our “deep-dives,” to identify and evaluate multiple, significant growth opportunities. Topix and New Mountain ultimately completed the transaction on a fully proprietary and exclusive basis in July 2016.